Atrial fibrillation with RVR: Difference between revisions
(Created page with "==Unstable (Cardioversion)== * Indications * Ischemic CP * SBP < 90 * Acute pulmonary edema * AMS * Above must be 2/2 RVR (i.e. if pulse is <130 look for other cause of above s...") |
No edit summary |
||
| Line 1: | Line 1: | ||
==Unstable (Cardioversion)== | ==Unstable (Cardioversion)== | ||
*Indications | |||
* Indications | **Ischemic CP | ||
* Ischemic CP | **SBP < 90 | ||
* SBP < 90 | **Acute pulmonary edema | ||
* Acute pulmonary edema | **AMS | ||
* AMS | *Above must be 2/2 RVR (i.e. if pulse is <130 look for other cause of above signs) | ||
* Above must be 2/2 RVR (i.e. if pulse is <130 look for other cause of above signs) | #Sedate: Versed / Ativan / Fentanyl | ||
#Initial 100J monophasic or 50-70j biphasic synchronized cardioversion | |||
==Stable but sympomatic (Rate Control)== | ==Stable but sympomatic (Rate Control)== | ||
*Goal < 110bpm1 | |||
* Goal < 110bpm1 | *Be careful that you are not slowing down a normal physiologic response! | ||
* Be careful that you are not slowing down a normal physiologic response! | **RVR in AF may be an appropriate response to fever, hypovolemia, hemorrhage, hypoxemia, withdrawal | ||
* RVR in AF may be an appropriate response to fever, hypovolemia, hemorrhage, hypoxemia, withdrawal | *No evidence that pharmacological rate control has any adverse influence on LV dysfunction | ||
* No evidence that pharmacological rate control has any adverse influence on LV dysfunction | |||
Calcium-Channel Blockers | Calcium-Channel Blockers | ||
*Preferred in pts with chronic lung disease or low EF | |||
* Preferred in pts with chronic lung disease or low EF | *Contraindications | ||
* Contraindications | **Decompensated heart failure | ||
* Decompensated heart failure | **Preexcitation | ||
* Preexcitation | **Significant hypotension | ||
* Significant hypotension | *Diltiazem | ||
* Diltiazem | **Bolus 0.25 mg/kg (average adult dose 20mg) over 2 min | ||
* Bolus 0.25 mg/kg (average adult dose 20mg) over 2 min | ***If, after 15 minutes the first dose is tolerated but inadequate, re-bolus 0.35 mg/kg (average adult dose 25 mg) | ||
* If, after 15 minutes the first dose is tolerated but inadequate, re-bolus 0.35 mg/kg (average adult dose 25 mg) | ***If pt responds to 1st or 2nd bolus start infusion at 5-15mg/hr | ||
* If pt responds to 1st or 2nd bolus start infusion at 5-15mg/hr | **Takes 2-5 minutes to work, last 1-4 hours | ||
* Takes 2-5 minutes to work, last 1-4 hours | **94% responive | ||
* 94% responive | **If effective, can start PO dilt at 30mg QID | ||
* If effective, can start PO dilt at 30mg QID | |||
Beta-Blockers | Beta-Blockers | ||
*Particularly useful with a fib associated with exercise, after an acute MI, or with thyrotoxicosis | |||
*Contraindicated in COPD, low EF CHF | |||
*Metoprolol | |||
**2.5-5mg IVP over 2min q5 min up to 3 doses | |||
*Esmolol | |||
**Use if unsure whether pt will tolerate a BB (duration of action is only 10-20min) | |||
**Bolus 0.5 mg/kg over one minute, followed by 50 µg/kg/min | |||
***If, after 4 minutes response is inadequate, re-bolus followed by infusion of 100 µg/kg/min | |||
***If, after 4 minutes response is still inadequate, try final bolus followed by infusion of 150 µg/kg/min | |||
***If necessary, infusion can be increased to maximum of 200 µg/kg/min after another four minutes | |||
*PO load with MTP 25-50mg following successful rate control with IV | |||
Digoxin | Digoxin | ||
*Consider as initial therapy for pts with LV dysfunction who: | |||
**Do not achieve rate control targets on beta blockers alone | |||
**Cannot tolerate addition of or increased doses of a beta blocker due to acute decompensated HF | |||
**Would have digoxin added anyway to improve CHF symptoms independent of AF | |||
*Consider as initial therapy in pts with severe hypotension | |||
*Consider as 2nd agent in pts in whom IV BB or IV CCB has failed to control their rate | |||
*May take up to 6-8 hours to work | |||
*Dosing | |||
**0.25 mg IV q2hr up to 1.5 mg, then 0.125-0.25 mg PO or IV QD | |||
**Adjust dose in presence of renal failure, amiodarone, etc | |||
Amiodarone | Amiodarone | ||
*Consider for use in pts with decompensated heart failure or those with accessory pathways | |||
* Consider for use in pts with decompensated heart failure or those with accessory pathways | *2nd-line agent for chronic rate control when BBs and CCBs, alone, combined, or when used with digoxin, are ineffective | ||
* 2nd-line agent for chronic rate control when BBs and CCBs, alone, combined, or when used with digoxin, are ineffective | *Load 5-7 mg/kg IV over 30 min; then 1200 mg over 24 h via continuous infusion or in divided oral doses | ||
* Load 5-7 mg/kg IV over 30 min; then 1200 mg over 24 h via continuous infusion or in divided oral doses | |||
==Stable and asymptomatic== | ==Stable and asymptomatic== | ||
* If mild or no symptoms and pulse only mildly elevated (<120bpm), ok to manage with PO meds | * If mild or no symptoms and pulse only mildly elevated (<120bpm), ok to manage with PO meds | ||
==Evidence of preexcitation== | ==Evidence of preexcitation== | ||
*Initial therapy is aimed at reversion to sinus rhythm | |||
**Unstable -> urgent cardioversion | |||
* Initial therapy is aimed at reversion to sinus rhythm | ***DC cardioversion | ||
* Unstable -> urgent cardioversion | ***Pharmacologic cardioversion | ||
* DC cardioversion | ****Procainamide | ||
* Pharmacologic cardioversion | *****20-50 mg/min until arrhythmia is controlled, hypotension occurs, QRS complex widens by 50% of original width, or total of 17 mg/kg is given; followed by continuous infusion of 1-4 mg/min | ||
* Procainamide | **Stable -> try to avoid cardioversion without adequate anticoagulation | ||
* 20-50 mg/min until arrhythmia is controlled, hypotension occurs, QRS complex widens by 50% of original width, or total of 17 mg/kg is given; followed by continuous infusion of 1-4 mg/min | **Avoid AV nodal agents | ||
* Stable -> try to avoid cardioversion without adequate anticoagulation | |||
* Avoid AV nodal agents | |||
==See also:== | ==See also:== | ||
Atrial Fibrillation (Gen) | Atrial Fibrillation (Gen) | ||
==Source == | ==Source == | ||
1/30/06 DONALDSON (adapted from Lampe), UpToDate, Niemann lecture | 1/30/06 DONALDSON (adapted from Lampe), UpToDate, Niemann lecture | ||
1RACE II study | 1RACE II study | ||
[[Category:Cards]] | [[Category:Cards]] | ||
Revision as of 18:29, 9 March 2011
Unstable (Cardioversion)
- Indications
- Ischemic CP
- SBP < 90
- Acute pulmonary edema
- AMS
- Above must be 2/2 RVR (i.e. if pulse is <130 look for other cause of above signs)
- Sedate: Versed / Ativan / Fentanyl
- Initial 100J monophasic or 50-70j biphasic synchronized cardioversion
Stable but sympomatic (Rate Control)
- Goal < 110bpm1
- Be careful that you are not slowing down a normal physiologic response!
- RVR in AF may be an appropriate response to fever, hypovolemia, hemorrhage, hypoxemia, withdrawal
- No evidence that pharmacological rate control has any adverse influence on LV dysfunction
Calcium-Channel Blockers
- Preferred in pts with chronic lung disease or low EF
- Contraindications
- Decompensated heart failure
- Preexcitation
- Significant hypotension
- Diltiazem
- Bolus 0.25 mg/kg (average adult dose 20mg) over 2 min
- If, after 15 minutes the first dose is tolerated but inadequate, re-bolus 0.35 mg/kg (average adult dose 25 mg)
- If pt responds to 1st or 2nd bolus start infusion at 5-15mg/hr
- Takes 2-5 minutes to work, last 1-4 hours
- 94% responive
- If effective, can start PO dilt at 30mg QID
- Bolus 0.25 mg/kg (average adult dose 20mg) over 2 min
Beta-Blockers
- Particularly useful with a fib associated with exercise, after an acute MI, or with thyrotoxicosis
- Contraindicated in COPD, low EF CHF
- Metoprolol
- 2.5-5mg IVP over 2min q5 min up to 3 doses
- Esmolol
- Use if unsure whether pt will tolerate a BB (duration of action is only 10-20min)
- Bolus 0.5 mg/kg over one minute, followed by 50 µg/kg/min
- If, after 4 minutes response is inadequate, re-bolus followed by infusion of 100 µg/kg/min
- If, after 4 minutes response is still inadequate, try final bolus followed by infusion of 150 µg/kg/min
- If necessary, infusion can be increased to maximum of 200 µg/kg/min after another four minutes
- PO load with MTP 25-50mg following successful rate control with IV
Digoxin
- Consider as initial therapy for pts with LV dysfunction who:
- Do not achieve rate control targets on beta blockers alone
- Cannot tolerate addition of or increased doses of a beta blocker due to acute decompensated HF
- Would have digoxin added anyway to improve CHF symptoms independent of AF
- Consider as initial therapy in pts with severe hypotension
- Consider as 2nd agent in pts in whom IV BB or IV CCB has failed to control their rate
- May take up to 6-8 hours to work
- Dosing
- 0.25 mg IV q2hr up to 1.5 mg, then 0.125-0.25 mg PO or IV QD
- Adjust dose in presence of renal failure, amiodarone, etc
Amiodarone
- Consider for use in pts with decompensated heart failure or those with accessory pathways
- 2nd-line agent for chronic rate control when BBs and CCBs, alone, combined, or when used with digoxin, are ineffective
- Load 5-7 mg/kg IV over 30 min; then 1200 mg over 24 h via continuous infusion or in divided oral doses
Stable and asymptomatic
- If mild or no symptoms and pulse only mildly elevated (<120bpm), ok to manage with PO meds
Evidence of preexcitation
- Initial therapy is aimed at reversion to sinus rhythm
- Unstable -> urgent cardioversion
- DC cardioversion
- Pharmacologic cardioversion
- Procainamide
- 20-50 mg/min until arrhythmia is controlled, hypotension occurs, QRS complex widens by 50% of original width, or total of 17 mg/kg is given; followed by continuous infusion of 1-4 mg/min
- Procainamide
- Stable -> try to avoid cardioversion without adequate anticoagulation
- Avoid AV nodal agents
- Unstable -> urgent cardioversion
See also:
Atrial Fibrillation (Gen)
Source
1/30/06 DONALDSON (adapted from Lampe), UpToDate, Niemann lecture
1RACE II study
